Alan J. Main - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
EVP, Innov & Chem Sciences
Signature
/s/ Alan J. Main, Ph.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$63,949
Form type
4
Date filed
2/29/2024, 04:30 PM
Previous filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +8.98K +4.22% 222K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +25.7K +11.58% 247K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +32.9K +13.31% 280K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$63.9K -24.4K -8.71% $2.62 256K Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -8.98K -100% 0 Feb 28, 2024 Common Stock 8.98K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -25.7K -50% 25.7K Feb 28, 2024 Common Stock 25.7K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32.9K -33.33% 65.8K Feb 28, 2024 Common Stock 32.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.